BG
TMDX icon

Bellevue Group’s Transmedics TMDX Stock Holding History

Bellevue Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.72M Hold
101,139
– – 0.14% 78
2026
Q1 		$10.1M Buy
101,139
+3,254
+3% +$424K 0.24% 61
2025
Q4 		$11.9M Sell
97,885
-19,083
-16% -$2.39M 0.23% 57
2025
Q3 		$13.1M Sell
116,968
-13,549
-10% -$1.59M 0.27% 59
2025
Q2 		$17.5M Sell
130,517
-43,193
-25% -$4.74M 0.39% 51
2025
Q1 		$11.7M Sell
173,710
-19,008
-10% -$1.31M 0.26% 67
2024
Q4 		$12M Buy
192,718
+22,874
+13% +$2.13M 0.23% 76
2024
Q3 		$26.7M Sell
169,844
-31,571
-16% -$4.86M 0.43% 66
2024
Q2 		$30.3M Sell
201,415
-162,649
-45% -$19.5M 0.49% 57
2024
Q1 		$26.9M Sell
364,064
-154,826
-30% -$12.8M 0.41% 70
2023
Q4 		$41M Sell
518,890
-17,847
-3% -$1.08M 0.63% 52
2023
Q3 		$29.4M Sell
536,737
-75,876
-12% -$5.46M 0.47% 62
2023
Q2 		$51.4M Sell
612,613
-16,871
-3% -$1.29M 0.73% 41
2023
Q1 		$47.7M Sell
629,484
-52,574
-8% -$3.64M 0.69% 50
2022
Q4 		$42.1M Buy
682,058
+28,244
+4% +$1.5M 0.56% 58
2022
Q3 		$27.3M Buy
653,814
+73,927
+13% +$3.22M 0.39% 68
2022
Q2 		$18.2M Sell
579,887
-1,142
-0.2% -$30.5K 0.26% 89
2022
Q1 		$15.7M Hold
581,029
– – 0.18% 99
2021
Q4 		$11.1M Hold
581,029
– – 0.11% 112
2021
Q3 		$19.2M Sell
581,029
-148,960
-20% -$4.55M 0.2% 103
2021
Q2 		$24.2M Sell
729,989
-12,211
-2% -$338K 0.24% 101
2021
Q1 		$30.8M Buy
742,200
+100,588
+16% +$3.1M 0.33% 89
2020
Q4 		$12.8M Buy
641,612
+64,465
+11% +$954K 0.15% 111
2020
Q3 		$7.95M Buy
577,147
+152,147
+36% +$2.61M 0.11% 116
2020
Q2 		$7.62M Buy
+425,000
New +$6.65M 0.11% 116

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Bellevue Group's TMDX Position: Q2 2026 in Review

Bellevue Group held its Transmedics (TMDX) position steady in Q2 2026 at 101,139 shares worth $6.72M. The position accounts for 0.14% of the portfolio, ranked #78.

Bellevue Group first reported a position in TMDX in Q2 2020 and has held it in 25 quarters since. The position peaked at $51.4M in Q2 2023. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Bellevue Group held 101,139 shares of Transmedics worth $6.72M as of Q2 2026.
  • Bellevue Group left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up 0.14% of Bellevue Group's portfolio in Q2 2026, its #78 holding.
  • Bellevue Group first reported a position in Transmedics in Q2 2020 and has held it in 25 quarters since.
  • Bellevue Group's Transmedics position peaked at $51.4M in Q2 2023.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.